low - Life insurance demand is relatively non-cyclical as middle-income households prioritize protection products regardless of GDP growth. However, high unemployment can pressure premium collections and increase policy lapses. Supplemental health products see modest cyclicality tied to employment levels since many are worksite-sold.

Rising interest rates are positive for Globe Life. Higher yields on new fixed income investments (portfolio duration ~10 years) increase excess investment income, which represents 25-30% of operating earnings. The company has minimal exposure to interest rate guarantees on in-force policies. Higher rates also improve statutory capital generation and reduce reserve requirements under actuarial assumptions. Conversely, prolonged low rates compress investment spreads.

value - The stock trades at 8.7x EV/EBITDA and 2.1x book value with 21% ROE, attracting value investors seeking consistent earnings, capital return (dividends and buybacks), and moderate growth. The 19% EPS growth despite 3.8% revenue growth reflects operational efficiency and share repurchases. Dividend-focused investors are drawn to the stable cash generation from insurance operations.